92.07
-1.18 (-1.27%)
| Penutupan Terdahulu | 93.25 |
| Buka | 92.66 |
| Jumlah Dagangan | 374,301 |
| Purata Dagangan (3B) | 1,000,868 |
| Modal Pasaran | 6,401,332,224 |
| Harga / Pendapatan (P/E TTM) | 15.29 |
| Harga / Pendapatan (P/E Ke hadapan) | 12.27 |
| Harga / Jualan (P/S) | 4.49 |
| Harga / Buku (P/B) | 5.58 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 20 Feb 2025 - 24 Feb 2025 |
| Margin Keuntungan | 28.57% |
| Margin Operasi (TTM) | 35.31% |
| EPS Cair (TTM) | 6.02 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 18.40% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -0.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 52.67% |
| Nisbah Semasa (MRQ) | 1.65 |
| Aliran Tunai Operasi (OCF TTM) | 499.31 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 246.27 M |
| Pulangan Atas Aset (ROA TTM) | 17.00% |
| Pulangan Atas Ekuiti (ROE TTM) | 45.53% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Lantheus Holdings, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 3.0 |
| Purata | 1.75 |
|
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 2.50% |
| % Dimiliki oleh Institusi | 106.98% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 143.00 (Goldman Sachs, 55.32%) | Beli |
| Median | 120.00 (30.34%) | |
| Rendah | 112.00 (JMP Securities, 21.65%) | Beli |
| Purata | 125.00 (35.77%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 90.42 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| JMP Securities | 14 Jan 2025 | 112.00 (21.65%) | Beli | 92.62 |
| 07 Nov 2024 | 112.00 (21.65%) | Beli | 88.32 | |
| Goldman Sachs | 18 Dec 2024 | 143.00 (55.32%) | Beli | 91.15 |
| Truist Securities | 08 Nov 2024 | 120.00 (30.34%) | Beli | 87.50 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |